MYELIN SYMPOSIUM 2026
8 May 2026 | Leipzig
News
Save the Date:
Programme
Certification: 10 CME points
X-linked Adrenoleukodystrophy: Past Achievements and Future Partnerships
Friday, 08.05.26
Schedule
08:00–08:30 Arrival and registration
08:30–08:40 Welcome and Introduction
Joseph Claßen, Leipzig 
Session 1: Histopathologic Features and Biological Foundations
Chairs:
Ruth Stassart, Leipzig & Florian Eichler, Boston
08:40–09:00 Myelin and Oligodendrocyte Research in Leipzig: Past and Future
Ruth Stassart, Leipzig
09:00–09:20 X-ALD Histopathology in the Context of White Matter Disorders
Christine Stadelmann, Göttingen
09:20–09:40 Organelle Pathology in X-ALD
Aurora Pujol, Barcelona
09:40–10:00 Biomarkers for Diagnosis and Monitoring of Disease Progression
Isabelle Weinhofer, Vienna & Johannes Berger, Vienna
10:05–10:15 Discussion
10:15–11:00 Coffee break
Session 2: Clinical Monitoring – Towards International Collaboration
Chairs:
Ludger Schöls, Tübingen & Ettore Salsano, Milano
11:00–11:15 European Collaborative Networks in Rare Diseases
Ludger Schöls, Tübingen
11:15–11:25 Federated Registries and International Databases for adult CALD
Julia Lier, Leipzig & Eda Kabak, Amsterdam
11:25–11:50 Clinical Monitoring of Disease Progression in Adrenomyeloneuropathy
Marc Engelen, Amsterdam
11:50–12:00 Neuropsychological Assessment in Adult Leukodystrophy Patients
Lisa Schäfer, Leipzig
12:00–12:10 Natural History of Cerebral Lesions in Adult X-ALD
Markus Ponleitner, Vienna
12:10–12:30 Discussion
12:30–13:30 Lunch break
Session 3: X-ALD Therapy
Chairs:
Ali Fatemi, Baltimore & Johannes Berger, Vienna
13:30–13:50 Emerging and Future Therapeutic Strategies in Leukodystrophies
Ali Fatemi, Baltimore
13:50–14:10 Lerigltazone - A New Treatment Option in ALD?
Fanny Mochel, Paris
14:10–14:30 HSCT and Gene Therapy in Childhood cALD
Troy Lund, Minneapolis
14:30–14:50 Long-term Outcomes in Transplanted Childhood Cerebral ALD
Jörn Kühl, Leipzig
14:50–15:05 Hematologic Standards in Adulthood Cerebral ALD Transplant
Georg Franke, Leipzig
15:05–15:20 Cellular Perspective on Neurologic Outcomes
Caroline Bergner, Leipzig
15:20–16:00 Targeting Cancer cells with Chimeric Antigen Receptors (CARs) – a “Blueprint” and potential new strategy in treating Leukodystrophies?
Ulrike Köhl, Leipzig
16:00–16:10 Discussion
16:10–16:30 Coffee break
Session 4: A Century of X-ALD Research: From Discovery to Future Perspectives
Chairs:
Ann Moser, Baltimore & Wolfgang Köhler, Leipzig
16:30–16:40 History of the Last 50 Years Progress in the Leukodystrophies
Ann Moser, Baltimore
16:40–17:10 100 years X-linked Adrenoleukodystrophy
Florian Eichler, Boston
17:10–17:30 Hope and Challenges - The Patient Perspective
Martin Büchler, ELA Deutschland
17:30–18:00 Past and Future: The German X-ALD Story and Closing Remarks
Wolfgang Köhler, Leipzig
Rahmenprogramm
18 Uhr Stadtführung
19 Uhr Konferenzdinner im Barthels Hof
CONTACT